NIKKEI 225
38,137.32 -136.73 (-0.36%) HANG SENG
17,763.03 0.00 (0.00%) CRUDE OIL
79.29 +0.29 (+0.37%) GOLD FUTURES
2,334.90 +23.90 (+1.03%) DOW
37,903.29 +87.37 (+0.23%) Bitcoin GBP
46,011.89 -2,009.96 (-4.19%)
Zymeworks Inc. (ZYME)
After hours:
- GlobeNewswire
Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: Bank of America Securities Health Care Conference: Zymeworks’ management will participate in one-on-one meetings on May 15th in Las
- Simply Wall St.
We Think Zymeworks (NASDAQ:ZYME) Can Afford To Drive Business Growth
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
- GlobeNewswire
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will report its first quarter 2024 financial results after market close on May 2, 2024. Following the announcement, management will host a conference call and webcast to discuss financial results a
